This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
Honeywell (HON) Boosts Organic Growth Path on New Contracts
by Zacks Equity Research
Honeywell International (HON) signs contracts with Deer Jet and Caprock Midstream.
Is a Surprise Coming for Danaher (DHR) This Earnings Season?
by Zacks Equity Research
Danaher (DHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.
Can Danaher (DHR) Maintain its Beat Streak in Q1 Earnings?
by Zacks Equity Research
Danaher (DHR) is likely to surpass first-quarter earnings on the back of strong performances in biopharma business, accretive acquisition strategies and solid portfolio of products.
United Technologies Expands GTF Engine Repair Supplier Base
by Zacks Equity Research
United Technologies (UTX) announces that it will include five repair suppliers in its global network of providers that maintain the Geared Turbofan engine.
Conglomerates Down 10.8% YTD, 4 Stocks That Beat the Odds
by Zacks Equity Research
Proposal of tariffs, higher raw material costs and concerns related to trade disputes are formidable risks for most conglomerates.
Dental Implant & Prosthetic Boom Puts Spotlight on 3 Stocks
by Gargi Seth
The dental market has outperformed the broader market in last ten years on the back of demand from both teenagers and adults.
Danaher Expands in Genetics with Integrated DNA Technologies
by Zacks Equity Research
Danaher (DHR) to buy Integrated DNA Technologies to expand into the genomics research market.
Danaher Raises Q1 View on Solid Prospects for Life Sciences
by Zacks Equity Research
Danaher (DHR) raises its outlook for first-quarter fiscal 2018 on strong segmental performance and accretive acquisitions.
The Zacks Analyst Blog Highlights: Bristol-Myers, Honda, Danaher, MetLife and V.F.
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Bristol-Myers, Honda, Danaher, MetLife and V.F.
Danaher (DHR) Q4 Earnings & Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Danaher (DHR) reported impressive fourth-quarter 2017 results driven by effective Danaher Business System.
Danaher (DHR) Beats on Q4 Earnings & Revenues, Guides Well
by Zacks Equity Research
Danaher Corporation (DHR) fourth-quarter earnings trumped estimates, and grows year over year.
Why Earnings Season Could Be Great for Danaher (DHR)
by Zacks Equity Research
Danaher (DHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Will Life-Sciences Growth Drive Danaher (DHR) Q4 Earnings?
by Zacks Equity Research
We expect Danaher (DHR) to beat fourth-quarter 2017 earnings on the back of strong revenues in Life Sciences & Diagnostics business.
United Technologies Hits 52-Week High on Solid Growth Trends
by Zacks Equity Research
With improving business conditions and strong operating fundamentals, United Technologies Corporation (UTX) expects to generate significant cash from operations for a healthy risk-adjusted return.
Danaher Issues '18 View Ahead of Investor & Analyst Meeting
by Zacks Equity Research
Danaher (DHR) initiates 2018 outlook, ahead of its annual investor and analyst meeting in New York City.
UTX's Pratt & Whitney Inks Deal to Manage S7 Airlines Fleet
by Zacks Equity Research
United Technologies Corporation's (UTX) operating segment Pratt & Whitney offers fleet management program that enhances the shelf life of engines and keeps them in perfect service conditions to reduce operating costs.
3M to Divest Communication Markets Business for $900 Million
by Zacks Equity Research
Over the years, 3M Company (MMM) has continuously pruned its businesses to improve customer relevance, productivity and speed through a leaner operating structure.
Pause, Trim, Reboot: GE Power Renders 12,000 Job Cuts
by Zacks Equity Research
The continued reduction in employee headcount is aimed at scripting a turnaround for General Electric Company (GE) by reducing operating costs and strengthening its liquidity.
GE to Lay Off 4,500 Employees in Europe for Reducing Costs
by Zacks Equity Research
The continued reduction in employee headcount is aimed at scripting a turnaround for General Electric Company (GE) by reducing operating costs and strengthening its liquidity.
Crane Co. to Buy Crane Currency, Reaffirms '17 Earnings View
by Zacks Equity Research
Crane Co's (CR) buyout of Crane Currency will strengthen its foothold in the currency and payments market. Earnings accretion from the buyout is anticipated from year one post completion.
Honeywell Augments Fire Business With SCAME Acquisition
by Zacks Equity Research
The acquisition of SCAME would create new business opportunities for Honeywell and make industrial sites across the globe more safe and secure.
Honeywell (HON) Retains Core Business Focus to Fuel Growth
by Zacks Equity Research
Honeywell International's (HON) diligent focus on working capital management, free cash flow generation and a conservative balance sheet remain key positives amid a challenging macroeconomic environment.
GE Stock Moves Up 1.6% Despite Fitch Ratings Downgrade
by Zacks Equity Research
Despite the negative undercurrent, General Electric's (GE) share price moved up as investors seemed to repose some faith in the latest restructuring process of the company.
Honeywell Hits 52-Week High on Favorable Growth Dynamics
by Zacks Equity Research
Healthy demand patterns and relatively bullish outlook probably drove Honeywell International (HON) shares to a new 52-week high.
GE Collaborates With NVIDIA for AI in Healthcare Products
by Zacks Equity Research
General Electric Company (GE) intends to leverage NVIDIA's AI computing platform to develop Revolution Frontier CT that is two times faster than the existing products available in the market.